Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

361 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension.
Ocular Hypertension Treatment Study Group; European Glaucoma Prevention Study Group; Gordon MO, Torri V, Miglior S, Beiser JA, Floriani I, Miller JP, Gao F, Adamsons I, Poli D, D'Agostino RB, Kass MA. Ocular Hypertension Treatment Study Group, et al. Among authors: torri v. Ophthalmology. 2007 Jan;114(1):10-9. doi: 10.1016/j.ophtha.2006.08.031. Epub 2006 Nov 7. Ophthalmology. 2007. PMID: 17095090 Free PMC article.
Bevacizumab for non-small-cell lung cancer.
Garassino MC, Hollander L, Torri V. Garassino MC, et al. Among authors: torri v. N Engl J Med. 2007 Mar 29;356(13):1373; author reply 1374-5. doi: 10.1056/NEJMc070042. N Engl J Med. 2007. PMID: 17392310 No abstract available.
In memoriam: Dr. Irene Claudia Floriani (1964-2016).
Torri V, Hollander L, Mazziotti G. Torri V, et al. Endocrine. 2016 Apr;52(1):178-9. doi: 10.1007/s12020-016-0891-z. Epub 2016 Feb 29. Endocrine. 2016. PMID: 26924151 No abstract available.
Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline Characteristics.
Quaranta L, Biagioli E, Galli F, Poli D, Rulli E, Riva I, Hollander L, Katsanos A, Longo A, Uva MG, Torri V, Weinreb RN. Quaranta L, et al. Among authors: torri v. Adv Ther. 2016 Aug;33(8):1305-15. doi: 10.1007/s12325-016-0358-x. Epub 2016 Jun 16. Adv Ther. 2016. PMID: 27312975 Free PMC article. Clinical Trial.
The Glaucoma Italian Pediatric Study (GIPSy): 1-Year Results.
Quaranta L, Biagioli E, Riva I, Galli F, Poli D, Rulli E, Katsanos A, Longo A, Uva MG, Torri V, Weinreb RN. Quaranta L, et al. Among authors: torri v. J Glaucoma. 2017 Nov;26(11):987-994. doi: 10.1097/IJG.0000000000000773. J Glaucoma. 2017. PMID: 28957960 Clinical Trial.
RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma.
Imbimbo M, Vitali M, Fabbri A, Ottaviano M, Pasello G, Petrini I, Palmieri G, Berardi R, Zucali P, Ganzinelli M, Marabese M, Broggini M, Marino M, Trama A, Rulli E, Hollander L, Pruneri G, Torri V, Garassino MC. Imbimbo M, et al. Among authors: torri v. Clin Lung Cancer. 2018 Sep;19(5):e811-e814. doi: 10.1016/j.cllc.2018.06.005. Epub 2018 Jul 3. Clin Lung Cancer. 2018. PMID: 30033090 Clinical Trial.
361 results